Valiant Commences Operations at Saykha Greenfield Facility

Valiant Advanced Sciences Private Limited, a wholly owned subsidiary of Valiant Laboratories Limited, has commenced commercial operations at its newly built greenfield manufacturing facility in Saykha GIDC, Bharuch, Gujarat. The commissioning marks a key milestone in the company’s strategic expansion, strengthening backward integration and enhancing its product portfolio in the specialty chemicals segment.

Focus on Acetic Anhydride Production

The Saykha plant produces Acetic Anhydride, a critical intermediate in the Ketene and Diketene derivatives value chain. The facility serves both domestic and global markets, aligning with growing demand in pharmaceuticals, agrochemicals, and performance chemicals. Equipped with advanced automation, robust safety systems, and environmental best practices, the plant ensures efficient and safe operations. It also houses a dedicated R&D center to support product innovation and future diversification.

Strategic Investment and Long-Term Growth Vision

The establishment of the Saykha facility represents a significant capital investment for the company and has been partially funded through the IPO proceeds of Valiant Laboratories Limited. The project reinforces Valiant’s long-term vision of enhancing supply chain integration and strengthening cost efficiency. It also supports the company’s plan to expand its footprint in global specialty chemical markets.

Commitment to Innovation and Sustainability

A company spokesperson noted that the new facility reflects Valiant’s commitment to sustainable growth and operational excellence. The plant leverages modern technology and process efficiencies to support India’s specialty chemical export growth while meeting stringent global quality standards.

Strong Legacy in Pharmaceutical Manufacturing

As reported by themachinemaker.com, Valiant Laboratories Limited has built a strong presence in the pharmaceutical sector. The company is particularly prominent in the Active Pharmaceutical Ingredient (API) market for Paracetamol. Founded in 1980, the company has grown steadily through its focus on reliability, quality, and adherence to rigorous manufacturing standards. The commissioning of the Saykha facility marks the next phase in the company’s evolution. It advances the move toward greater value-added chemical manufacturing and global competitiveness.